{{Rsnum
|rsid=10868138
|Gene=SLC28A3
|Chromosome=9
|position=84302386
|Orientation=plus
|GMAF=0.1051
|Gene_s=SLC28A3
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;T)
| geno3=(T;T)
| CEU | 0.9 | 17.9 | 81.2
| HCB | 0.7 | 15.3 | 83.9
| JPT | 0.0 | 12.4 | 87.6
| YRI | 6.2 | 31.5 | 62.3
| ASW | 5.3 | 29.8 | 64.9
| CHB | 0.7 | 15.3 | 83.9
| CHD | 3.7 | 12.0 | 84.3
| GIH | 0.0 | 5.9 | 94.1
| LWK | 1.8 | 29.1 | 69.1
| MEX | 0.0 | 12.1 | 87.9
| MKK | 1.3 | 11.5 | 87.2
| TSI | 0.0 | 12.7 | 87.3
| HapMapRevision=28
}}{{PMID Auto
|PMID=22118055
|Title=Single and combined IL28B, ITPA and SLC28A3 host genetic markers modulating response to anti-hepatitis C therapy
}}

{{PMID Auto
|PMID=21346688
|Title=Role of nucleoside transporters SLC28A2/3 and SLC29A1/2 genetics in ribavirin therapy: protection against anemia in patients with chronic hepatitis C.
}}

{{GET Evidence
|gene=SLC28A3
|aa_change=Tyr113Cys
|aa_change_short=Y113C
|impact=not reviewed
|qualified_impact=Insufficiently evaluated not reviewed
|inheritance=unknown
|quality_scores=Array
|dbsnp_id=rs10868138
|overall_frequency_n=1190
|overall_frequency_d=10758
|overall_frequency=0.110615
|n_genomes=9
|n_genomes_annotated=0
|n_haplomes=10
|n_articles=0
|n_articles_annotated=0
|pph2_score=0.137
|nblosum100=6
|autoscore=0
|webscore=N
}}

{{PMID Auto
|PMID=23195617
|Title=Impact of genetic SLC28 transporter and ITPA variants on ribavirin serum level, hemoglobin drop and therapeutic response in patients with HCV infection
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | FTDNA}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}